Benzinga.com

Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter

For the fourth quarter of 2025, Ginkgo Bioworks reported a strategic pivot towards robotics and AI, with CEO Jason Kelly emphasizing the company’s collaboration with the Department of Energy and ...
Nasdaq

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

International consortium to develop rapid metagenomic NGS solutions that can identify known and novel respiratory pathogens, reduce time-to-diagnosis, and enhance hospital decision-making and public ...
The Business Journals

Ginkgo Bioworks says layoffs will continue through mid-2025

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Ginkgo Bioworks Holdings Inc. is ...
GEN

Ginkgo Bioworks Awarded Project Agreement Through BARDA’s BioMaP-Consortium

Ginkgo Bioworks has been awarded a contract through the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium).
STAT

Ginkgo Bioworks bets on protein AI model and data generation to turn struggling company around

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Amid layoffs and a disintegrating share ...